Literature DB >> 17030701

The inflammatory hypothesis: any progress in risk stratification and therapeutic targets?

Stefan Blankenberg, Salim Yusuf.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17030701     DOI： 10.1161/CIRCULATIONAHA.106.652081

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  7 in total

Review 1.  Emerging role of Toll-like receptors in atherosclerosis.

Authors:  Linda K Curtiss; Peter S Tobias
Journal:  J Lipid Res       Date:  2008-11-01       Impact factor: 5.922

2.  Plasma lipoprotein-associated phospholipase A2 levels in heart failure: association with mortality in the community.

Authors:  Yariv Gerber; Shannon M Dunlay; Allan S Jaffe; Joseph P McConnell; Susan A Weston; Jill M Killian; Véronique L Roger
Journal:  Atherosclerosis       Date:  2008-08-07       Impact factor: 5.162

Review 3.  Insight into the mode of action of ACE inhibition in coronary artery disease: the ultimate 'EUROPA' story.

Authors:  Roberto Ferrari; Kim Fox
Journal:  Drugs       Date:  2009       Impact factor: 9.546

Review 4.  TLR2 in murine atherosclerosis.

Authors:  Peter S Tobias; Linda K Curtiss
Journal:  Semin Immunopathol       Date:  2007-12-06       Impact factor: 9.623

5.  Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease.

Authors:  Surya Ramachandran; Anila Venugopal; V Raman Kutty; Vinitha A; Divya G; V Chitrasree; Ajit Mullassari; N S Pratapchandran; K R Santosh; M Radhakrishna Pillai; C C Kartha
Journal:  Cardiovasc Diabetol       Date:  2014-02-07       Impact factor: 9.951

Review 6.  C-reactive protein: clinical and epidemiological perspectives.

Authors:  Juan Salazar; María Sofía Martínez; Mervin Chávez; Alexandra Toledo; Roberto Añez; Yaquelín Torres; Vanessa Apruzzese; Carlos Silva; Joselyn Rojas; Valmore Bermúdez
Journal:  Cardiol Res Pract       Date:  2014-02-06       Impact factor: 1.866

7.  The Lipid Paradox is present in ST-elevation but not in non-ST-elevation myocardial infarction patients: Insights from the Singapore Myocardial Infarction Registry.

Authors:  Ching-Hui Sia; Huili Zheng; Andrew Fu-Wah Ho; Heerajnarain Bulluck; Jun Chong; David Foo; Ling-Li Foo; Patrick Zhan Yun Lim; Boon Wah Liew; Huay-Cheem Tan; Tiong-Cheng Yeo; Terrance Siang Jin Chua; Mark Yan-Yee Chan; Derek J Hausenloy
Journal:  Sci Rep       Date:  2020-04-22       Impact factor: 4.379
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.